Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07728461

Menopause and Compassionate Living Education

Menopause is a natural stage in a woman's life characterized by the permanent cessation of ovarian function and is frequently accompanied by vasomotor, psychological, urogenital, and sleep-related symptoms that can substantially impair quality of life. Although pharmacological treatments are available, many women seek non-pharmacological interventions to manage menopausal symptoms and improve their overall well-being. Mindfulness- and compassion-based interventions have shown promising effects on psychological health, stress reduction, and quality of life in different populations; however, evidence regarding the effectiveness of Mindfulness-Based Compassionate Living (MBCL) for women experiencing menopause remains limited.

This randomized controlled trial aims to evaluate the effectiveness of a Compassionate Living Education Program based on the principles of Mindfulness-Based Compassionate Living in improving symptom management and quality of life among menopausal women. The study will be conducted with menopausal women recruited from primary healthcare settings in Kars, Türkiye. Participants who meet the eligibility criteria will be randomly assigned to either an intervention group or a control group.

Participants in the intervention group will receive an eight-session online Compassionate Living Education Program delivered by a certified instructor. The program includes mindfulness practices, self-compassion exercises, breathing and relaxation techniques, compassionate imagery, loving-kindness meditation, and home practice assignments designed to strengthen emotional regulation, self-kindness, and adaptive coping skills. The control group will receive routine care only.

Primary outcomes will include menopausal symptom severity and menopause-specific quality of life. Secondary outcomes will include self-compassion, mindfulness, anxiety, depression, and stress. Data will be collected using validated self-report questionnaires before and after the intervention and analyzed using appropriate statistical methods.

The findings of this study are expected to provide evidence regarding the effectiveness of Compassionate Living Education as an accessible, low-cost, non-pharmacological intervention for improving symptom management and enhancing the quality of life of menopausal women. The results may contribute to the development of evidence-based nursing and women's health interventions in primary healthcare settings.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Mindfulness Compassionate Living Training

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ataturk University Vocational School of Health Services

Erzurum, Yakutiye, Turkey (Türkiye)

Location contact

Mine Cengiz, Phd

CONTACT

[email protected]

05308864974

Nazlı Sezer, Assistant Professor

SUB_INVESTIGATOR

Sibel Öztürk, Assoc. prof.

SUB_INVESTIGATOR

About this study

Menopause is associated with physical, psychological, and social symptoms that may negatively affect women's quality of life. Effective non-pharmacological interventions are needed to improve symptom management during this period. Mindfulness-Based Compassionate Living (MBCL) has shown promising effects on psychological well-being and self-compassion in different populations. However, evidence regarding its effectiveness among menopausal women remains limited. This randomized controlled trial aims to evaluate the effects of Compassionate Living Education on menopausal symptom management and quality of life. Eligible participants will be randomly assigned to either an intervention group or a control group. The intervention group will participate in an eight-session online Compassionate Living Education Program, while the control group will receive routine care. Primary outcomes include menopausal symptom severity and menopause-specific quality of life. Secondary outcomes include self-compassion, mindfulness, anxiety, depression, and stress. The findings are expected to provide evidence for an accessible, low-cost, and evidence-based intervention to support women during the menopausal transition.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women who are in the menopausal period.
  • Aged 45 years or older.
  • Registered at the participating primary healthcare center.
  • Able to read and understand Turkish.
  • At least a primary school graduate.
  • Willing to participate and provide written informed consent.
  • Able to attend the online Compassionate Living Education sessions.
  • Able to complete the study questionnaires.

Exclusion criteria

  • Failure to complete the study questionnaires.
  • Failure to attend the Compassionate Living Education sessions.
  • Withdrawal of informed consent at any stage of the study.
  • Inability to complete the post-intervention assessment.

Treatment and study plan

Session 1: How We Evolved - Threat, Impulse, and Soothing Systems

Behavioral

The practice of "Breath break with kindness" will be applied for 5 minutes. Afterwards, 15 minutes of information on threats, impulses and soothing systems, "A safe place" application for 11 minutes, "Courtesy meditation" for 10 minutes. After each application, 10 minutes of feedback will be received from the participants.

Session 2: Threat and Self-Compassion

Behavioral

The practice of "breathing with kindness" will be done for 7 minutes. The practice of "Building a compassionate relationship with resilience" will be held for 12 minutes, and the practice of "Kindness meditation: a benevolent" will take place for 11 minutes. "A hand over your heart" application will be made for 3 minutes and "A compassionate comrade" application will be done for 10 minutes. After each application, 3 minutes of feedback will be received from the participants.

Session 3: Unraveling the Knots of Desire and Patterns

Behavioral

The practice of "breathing with kindness" will be done for 7 minutes. "Building a compassionate relationship with desire" 12 minutes, "Guided meditation to discover the inner pattern" 10 minutes and "Courtesy meditation: a good friend" 11 minutes. Except for the "breath break with kindness" application, 3 minutes of feedback will be received from the participants after each application

Session 4: Internalizing compassion

Behavioral

The "pretend-to-be" practice for the participants to observe themselves will be made for 10 minutes. The practice of "internalizing compassion" will be done for 7 minutes, "kindness meditation: a neutral person" practice for 10 minutes, and "kindness towards your body" for 10 minutes. After each application, 3 minutes of feedback will be received from the participants.

Session 5: Me and others - Expanding the circle

Behavioral

The "a compassionate letter" practice with the participants will continue for 15 minutes. "meditation: the 'difficult' person" 8 minutes, "compassion and breathing: yourself" 10 minutes and "compassionate breathing: others" 7 minutes. A "compassionate break" application is performed for 7 minutes.

Session 6: Growing happiness

Behavioral

The practice of "Revisiting the good" is carried out for 10 minutes with the participants. "Forgive yourself", "wish for forgiveness", "forgive others", "gratitude" practices will be held for 5 minutes each and will take 20 minutes in total. "Courtesy meditation: groups and all beings" will be practiced for 10 minutes. After each application, 3 minutes of feedback will be received from the participants

Session 7: Weaving Wisdom and Compassion into Daily Life

Behavioral

Participants will be given 10 minutes to choose a day in their life and allow a few minutes to pause mindfully. The practice of "a breather for wise and compassionate action" is 10 minutes, the practice of "calmness meditation" is 8 minutes, and the practice of "sharing the joy meditation" is 8 minutes. After each application, 3 minutes of feedback will be received from the participants.

Session 8: Living with the Heart

Behavioral

The participants are told about the applications they can apply for, where they need help to develop compassion towards self-healing skills, and the entire training will be evaluated for 20 minutes. The "river of life" application is carried out for 20 minutes. 10 minutes of feedback will be received after the application.

Primary outcomes

  1. Menopausal Symptom Assessment Scale/MSSA (Appendix-2)

    Time frame: up to 1 day

    Developed by Schneider et al. in 1992 to measure the severity of menopausal symptoms and their impact on quality of life, the Turkish validity and reliability of this scale was established by Gürkan (Gürkan, 2005). The scale, consisting of 11 items covering menopausal complaints, comprises 3 sub-dimensions: 1- Somatic complaints (items 1, 2, 3, 11), 2- Psychological complaints (items 4, 5, 6, 7), and 3- Urogenital complaints (items 8, 9, 10). The scale uses a 5-point Likert scale, with each item scored from 0: None, 1: Mild, 2: Moderate, 3: Severe, and 4: Very severe. The total score of the scale is calculated based on the scores given for each item. The minimum score obtainable from the scale is 0, while the maximum score is 44. An increase in the total score obtained from the scale indicates an increase in the severity of the complaints experienced, and on the other hand, it shows that the quality of life is negatively affected.

Secondary outcomes

  1. Menopause-Specific Quality of Life Scale (MSQLS) (Appendix-3)

    Time frame: up to 1 day

    Developed by Hilditch et al. (1996), its Turkish validity and reliability were established by Kharbouch and Şahin (2007). The MSQLS consists of four sub-dimensions: vasomotor, psychosocial, physical, and sexual, and contains 29 statements on a six-point Likert scale. In the MSQLS, each sub-area is scored between 0-6. A score of "0" indicates that no problems are experienced regarding the issue, a score of "1" indicates that the problem exists but does not bother anyone, and scores between "2-6" indicate the severity and increasing degree of the existing problem. The lowest possible score on the scale is "0", and the highest is 154. An increase in the score obtained from the MÖYKÖ indicates an increase in the severity of the complaint and a decrease in quality of life. The MÖYKÖ is not evaluated based on the total score. In the original study, the Cronbach's alpha values for the sub-dimensions of the scale were found to b

Other outcomes

  1. Self-Compassion Scale Short Form (SCS-S) (Appendix-4)

    Time frame: up to 1 day

    Developed by Neff (2003), the scale's Turkish validity and reliability were established by Yıldırım and Sarı in 2018. The scale was confirmed to consist of 11 items, a single dimension, and two complementary components (positive and negative components). The internal consistency coefficient of the scale was calculated as 0.75. The SCS-S is recommended for use in research where total scores are used to measure self-compassion.

  2. Mindfulness Awareness Scale (MAS) (Appendix-5)

    Time frame: up to 1 day

    Developed by Brown and Ryan (2003) to assess individuals' level of mindfulness. Its Turkish validity and reliability were established by Özyeşil et al. (2011). The scale is a 15-item, single-dimensional scale using a six-point Likert scale. The Cronbach's alpha coefficient of the scale was determined to be 0.80. The minimum and maximum scores individuals can obtain on the scale range from 15 to 90. Higher scores indicate a high level of cognitive impairment.

Study contacts

Contact information is provided by the study sponsor or research team.

Mine Cengiz, lecturer doctor

CONTACT

[email protected]

+905308864974

Sponsors and collaborators

Lead sponsor

Ataturk University

Other

Registry information

Official study title

The Effect of Compassionate Living Education on Symptom Management and Quality of Life in Menopausal Women: A Randomized Controlled Study

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Jul 27, 2026
Registry last updated
Jul 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.